82 filings
8-K
OTIC
Otonomy, Inc.
30 Mar 23
Other Events
4:17pm
8-K
OTIC
Otonomy, Inc.
28 Mar 23
Material Modifications to Rights of Security Holders
9:16am
8-K
OTIC
Otonomy, Inc.
16 Feb 23
Results of Operations and Financial Condition
5:09pm
8-K
OTIC
Otonomy, Inc.
30 Jan 23
Departure of Directors or Certain Officers
6:09am
8-K
OTIC
Otonomy, Inc.
29 Dec 22
Termination of a Material Definitive Agreement
4:05pm
8-K
5iyyl2 rrndnv3fj
22 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10:59am
8-K
dnfriy
19 Dec 22
Otonomy Provides Corporate Update
5:27pm
8-K
jbgq bwumpe
18 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
vmifh0 n2up
10 Nov 22
Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:22pm
8-K
uti9iqok9zi
24 Oct 22
Other Events
6:06am
8-K
f8mhgb63tcs zl7g0b
14 Oct 22
Results of Operations and Financial Condition
6:06am
8-K
mevoz8 lo0ewobnbaq
16 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:03pm
8-K
methspeqssut98ri
9 Aug 22
Cost Associated with Exit or Disposal Activities
12:00am
8-K
8y6oipvbkm lcp0d
1 Aug 22
Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
4:11pm
8-K
477noebd15t4frkx
25 Jul 22
Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:11pm
8-K
xatv8ze1
23 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
d5aayuar2fxtt
9 May 22
Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:13pm
8-K
vx7wltcm
20 Apr 22
Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss
7:35am
8-K
85eu1b38s 90w9
28 Feb 22
Otonomy Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:12pm
8-K
hk44dgo
6 Jan 22
Otonomy Reports Corporate and Product Pipeline Update
7:30am